2m 2m 2m 2m 2m 2m 2m
Emergent BioSolu (EBS)
NYSE
$6.15-$0.09 (-1.36%)
Price as of Sep 11, 2026 7:59 PM EDT- $319.4MMarket Cap
- -23.46%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Emergent BioSolu (EBS)
$6.15-$0.09 (-1.36%)
EBS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.23 | ||
Change | +$0.36 (+6.13%) | ||
Open | $5.98 | ||
High | $6.39 | ||
Low | $5.88 | ||
Previous Close | $5.87 | ||
Volume | 1,299,158 | ||
30-Day Average Volume | 1,223,633 | ||
1-Week Change | 0.32% | ||
1-Month Change | 40.00% | ||
1-Year Change | -23.46% | ||
3-Year Change | 47.63% | ||
5-Year Change | -89.09% | ||
Fundamentals | |||
Shares Outstanding | 51.3M | ||
Total Assets | $1.1B | ||
Market Cap | $319.4M | ||
Enterprise Value | $761.5M | ||
Period: QTR TTM FY | |||
Revenue | $226.8M | ||
Net Income | -$180.2M | ||
Free Cash Flow | $54.0M | ||
EBIT | -$166.3M | ||
EBITDA | -$142.3M | ||
Net Working Capital | $543.2M | ||
EPS | -$3.49 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | 6 | ||
Price/Operating Cash Flow | 6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue